News FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis Companies hope tanezumab offers alternative to opioids
News FDA makes unprecedented move, asks Endo to pull painkiller f... Regulator concerned about potential abuse of Opana ER
News FDA to review Novartis CAR-T next month If all goes well, FDA could approve CTL109 by late September
News Safety restrictions spell the end for Servier osteoporosis d... Sales of Protelos hit by safety restrictions.
News FDA approves first ALS treatment for two decades FDA asked Mitsubishi to file Radicava following approval in Japan.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
